Loading...
Northwest Biotherapeutics, Inc.
NWBO•PNK
Healthcare
Biotechnology
$0.26
$0.005(2.12%)
Northwest Biotherapeutics, Inc. (NWBO) Financial Performance & Income Statement Overview
Review Northwest Biotherapeutics, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-28.47%
↓ 28.47%
Operating Income Growth
-19.82%
↓ 19.82%
Net Income Growth
-33.83%
↓ 33.83%
Operating Cash Flow Growth
-6.30%
↓ 6.30%
Operating Margin
-4621.52%
↓ 4621.52%
Gross Margin
100.00%
↑ 100.00%
Net Profit Margin
-5775.56%
↓ 5775.56%
ROE
112.97%
↑ 112.97%
ROIC
122.54%
↑ 122.54%
Northwest Biotherapeutics, Inc. (NWBO) Income Statement & Financial Overview
Review Northwest Biotherapeutics, Inc.'s (NWBO) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $231000.00 | $357000.00 | $510000.00 | $284000.00 |
| Cost of Revenue | $501000.00 | $0.00 | $516000.00 | $505000.00 |
| Gross Profit | -$270000.00 | $357000.00 | -$6000.00 | -$221000.00 |
| Gross Profit Ratio | -$1.17 | $1.00 | -$0.01 | -$0.78 |
| R&D Expenses | $10.52M | $8.13M | $8.29M | $7.94M |
| SG&A Expenses | $8.21M | $7.03M | $9.68M | $7.58M |
| Operating Expenses | $18.73M | $15.16M | $17.97M | $15.52M |
| Total Costs & Expenses | $18.73M | $15.16M | $17.97M | $16.03M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $2.49M | $2.08M | $1.68M | $1.52M |
| Depreciation & Amortization | $501000.00 | $522000.00 | $516000.00 | $505000.00 |
| EBITDA | -$25.23M | -$16.77M | -$15.67M | -$16.29M |
| EBITDA Ratio | -$109.24 | -$46.98 | -$30.73 | -$57.36 |
| Operating Income | -$18.50M | -$14.80M | -$17.46M | -$15.74M |
| Operating Income Ratio | -$80.08 | -$41.46 | -$34.24 | -$55.44 |
| Other Income/Expenses (Net) | -$9.72M | -$4.57M | -$405000.00 | -$2.57M |
| Income Before Tax | -$28.22M | -$19.37M | -$17.87M | -$18.31M |
| Income Before Tax Ratio | -$122.18 | -$54.27 | -$35.04 | -$64.48 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $461724.00 |
| Net Income | -$28.22M | -$19.37M | -$17.87M | -$18.31M |
| Net Income Ratio | -$122.18 | -$54.27 | -$35.04 | -$64.48 |
| EPS | -$0.02 | -$0.02 | -$0.02 | -$0.02 |
| Diluted EPS | -$0.02 | -$0.02 | -$0.02 | -$0.02 |
| Weighted Avg Shares Outstanding | $1.29B | $1.26B | $1.21B | $1.19B |
| Weighted Avg Shares Outstanding (Diluted) | $1.29B | $1.26B | $1.21B | $1.19B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan